Editor's Memo
John Marcille
Brad Wilson
Brad Wilson

By segmenting services, employers limit their ability to leverage powerful data analyses that drive health improvement and cost reduction.

Legislation & Regulation
John Carroll
Health plan officials are not doing handstands over the federal government’s extension of a deadline to disclose benefits to members in a readable form
Medication Management
Thomas Reinke
Insurers feel pressure to incorporate new agents into their drug benefit, but evidence of effectiveness is questionable
Evidence Review
A summary of ECRI Institute’s Health Technology Forecast Report
Frank Diamond
Employers and the federal government like these programs, but some question their cost-effectiveness
Tomorrow's Medicine
Thomas Morrow, MD
There are many genetic mutations attributable to the condition, but Kalydeco can significantly help a specific subpopulation of patients
News & Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report